Are you Dr. Morris?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4574 PO Box
Crestline, CA 92325Phone+1 909-533-7180Fax+1 909-338-5211
Summary
- Dr. Michael Morris, MD is an obstetrician/gynecologist in Crestline, California. He is currently licensed to practice medicine in California, Arkansas, and Illinois.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Obstetrics and Gynecology, 1974 - 1975
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Transitional Year, 1970 - 1971
- Weill Cornell MedicineClass of 1970
Certifications & Licensure
- IL State Medical License 1971 - Present
- CA State Medical License 1972 - 2025
- AR State Medical License 1998 - 2000
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2014
- New York Magazine: Top Doctors Castle Connolly, 2013
Clinical Trials
- Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer Start of enrollment: 2007 Feb 01
Publications & Presentations
PubMed
- 139 citationsSafety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cance...Karen A. Autio, Robert Dreicer, Justine Anderson, Jorge A. Garcia, Ajjai Alva
JAMA Oncology. 2018-10-01 - 168 citationsA Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Frédéric Pouliot
The Journal of Urology. 2021-02-26 - 13 citationsClinical Outcomes in Men of Diverse Ethnic Backgrounds with Metastatic Castration Resistant Prostate CancerSusan Halabi, Sandipan Dutta, Catherine M. Tangen, M. Rosenthal, Daniel P. Petrylak
Annals of Oncology. 2020-07-01